For: | Liu YM, Qin H, Wang CB, Fang XH, Ma QY. Comparison of therapeutic effectiveness of combined interventional therapy for 1126 cases of primary liver cancer. World J Gastroenterol 2006; 12(31): 5060-5063 [PMID: 16937507 DOI: 10.3748/wjg.v12.i31.5060] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i31/5060.htm |
Number | Citing Articles |
1 |
Xuan Shui, Jian Huang, Yue-Hui Li, Ping-Li Xie, Guan-Cheng Li. Construction and Selection of Human Fab Antibody Phage Display Library of Liver Cancer. Hybridoma 2009; 28(5): 341 doi: 10.1089/hyb.2009.0028
|
2 |
Fan Pingsheng, Zhang Tengyue, Huang Qiang, Wei Qiang, Sun Xin, Qian Liting. Basic and Clinical Research on the Therapeutic Effect of Intervention in Primary Liver Cancer by Targeted Intra-Arterial Verapamil Infusion. Cell Biochemistry and Biophysics 2012; 62(1): 59 doi: 10.1007/s12013-011-9259-4
|
3 |
Jin Huang, Qiaohong Duan, Pingsheng Fan, Chushu Ji, Yuying Lv, Xinmin Lin, Liting Qian, Xiukun Yu. Clinical Evaluation of Targeted Arterial Infusion of Verapamil in the Interventional Chemotherapy of Primary Hepatocellular Carcinoma. Cell Biochemistry and Biophysics 2011; 59(2): 127 doi: 10.1007/s12013-010-9125-9
|
4 |
Atsushi Nanashima, Takeshi Nagayasu, Terumitsu Sawai, Shigekazu Hidaka, Kenji Tanaka, Takashi Nonaka, Yorihisa Sumida, Satoshi Miuma, Junichi Masuda. Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score. World Journal of Gastroenterology 2008; 14(1): 58-63 doi: 10.3748/wjg.14.58
|
5 |
De-Sheng Weng, Jun Zhou, Qi-Ming Zhou, Ming Zhao, Qi-Jing Wang, Li-Xi Huang, Yong-Qiang Li, Shi-Ping Chen, Pei-Hong Wu, Jian-Chuan Xia. Minimally Invasive Treatment Combined With Cytokine-induced Killer Cells Therapy Lower the Short-term Recurrence Rates of Hepatocellular Carcinomas. Journal of Immunotherapy 2008; 31(1): 63 doi: 10.1097/CJI.0b013e31815a121b
|
6 |
Xinyang Liu, Zhichao Wang, Zongwei Chen, Longzi Liu, Lijie Ma, Liangqing Dong, Zhao Zhang, Shu Zhang, Liuxiao Yang, Jieyi Shi, Jia Fan, Xiaoying Wang, Qiang Gao. Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(2): 231 doi: 10.3727/096504017X15051752095738
|
7 |
Jiayang Li, Kejian Shi, Zeinab Farhadi Sabet, Wenjiao Fu, Huige Zhou, Shaoxin Xu, Tao Liu, Min You, Mingjing Cao, Mengzhen Xu, Xuejing Cui, Bin Hu, Ying Liu, Chunying Chen. New power of self-assembling carbonic anhydrase inhibitor: Short peptide–constructed nanofibers inspire hypoxic cancer therapy. Science Advances 2019; 5(9) doi: 10.1126/sciadv.aax0937
|
8 |
Arindam Bharadwaz, Kirstine Petrea Bak-Fredslund, Gerda Elisabeth Villadsen, Jens Erik Nielsen, Kira Simonsen, Thomas Damgaard Sandahl, Henning Grønbæk, Dennis Tønner Nielsen. Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: experience from a Danish tertiary liver center. Acta Radiologica 2016; 57(7): 844 doi: 10.1177/0284185115603246
|
9 |
Xuanbin Wang, Ning Wang, Fan Cheung, Lixing Lao, Charlie Li, Yibin Feng. Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms. Journal of Integrative Medicine 2015; 13(3): 142 doi: 10.1016/S2095-4964(15)60171-6
|
10 |
Andrew Kennedy, Douglas Coldwell, Bruno Sangro, Harpreet Wasan, Riad Salem. Integrating Radioembolization (90Y Microspheres) Into Current Treatment Options for Liver Tumors. American Journal of Clinical Oncology 2012; 35(1): 81 doi: 10.1097/COC.0b013e3181ec60b8
|